Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies	Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, adenocarcinoma, breast disorder, breast neoplasm, cancer, carcinoma, epithelial neoplasm, lung cancer, lung disorder, lung neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, triple-negative breast carcinoma	Active, not recruiting	Phase 1	2026-08-26		NCT06577987

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Circle Pharma	1

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Comprehensive Cancer Centers of Nevada	Las Vegas	United States	34
Dana Farber Cancer Institute	Boston	United States	300
Florida Cancer Specialists	Sarasota	United States	47
MD Anderson Cancer Center	Houston	United States	589
NEXT Oncology	San Antonio	United States	70
Oregon Health and Science University	Portland	United States	382
Sarah Cannon Research Institute	Nashville	United States	119
START Midwest	Grand Rapids	United States	79
START Mountain	West Valley City	United States	5
UH Seidman Cancer Center	Cleveland	United States	3